CD25 Monoclonal Antibody(Q22)

The interleukin 2 (IL2) receptor alpha (IL2RA) and beta (IL2RB) chains, together with the common gamma chain (IL2RG), constitute the high-affinity IL2 receptor. Homodimeric alpha chains (IL2RA) result in low-affinity receptor, while homodimeric beta (IL2RB) chains produce a medium-affinity receptor. Normally an integral-membrane protein, soluble IL2RA has been isolated and determined to result from extracellular proteolyisis. Alternately-spliced IL2RA mRNAs have been isolated, but the significance of each is presently unknown. Mutations in this gene are associated with interleukin 2 receptor alpha deficiency.

The CD25 Monoclonal Antibody (Q22) is a highly effective and reliable product that has been specifically designed for use in a wide range of research applications. This antibody is a monoclonal antibody that has been developed to target the CD25 antigen, which is expressed on the surface of activated T cells and regulatory T cells. The CD25 Monoclonal Antibody (Q22) has been extensively tested and validated for use in a variety of applications, including flow cytometry, immunohistochemistry, and western blotting.

This product is manufactured to the highest standards of quality and purity, ensuring that it delivers consistent and reliable results every time it is used. The CD25 Monoclonal Antibody (Q22) is supplied in a convenient and easy-to-use format, making it ideal for use in both academic and industrial research settings.

In summary, the CD25 Monoclonal Antibody (Q22) is a highly effective and reliable product that is specifically designed for use in a wide range of research applications. Its high quality and purity, combined with its ease of use, make it an ideal choice for researchers looking to achieve accurate and reliable results in their experiments.